Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
Triple Negative Breast Neoplasms
×
Carboplatin
×
Clear all
Filters
3
NCT06829199
2026-02-19
MK-5890-003
Merck Sharp & Dohme LLC
Phase 2
Withdrawn
NCT05809895
2023-07-24
AdvanTIG-211
Novartis
Phase 2
Withdrawn